Pure Global AI
NCT06017349Completed

To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose Measurement

A Prospective, Multicenter, Open-label, Self-controlled Clinical Trial Protocol to Evaluate the Efficacy and Safety of a Multi-parameter Non-Invasive Glucose Sensors for Measuring Blood Glucose.
Lepu Medical Technology (Beijing) Co., Ltd.ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Non-invasive glucose meter
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Lepu Medical Technology (Beijing) Co., Ltd.
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Sep 21, 2022
End date
Jul 18, 2023
Enrollment
200 participants
Primary outcome

The results were analyzed by consensus error grid (CEG)

Summary

This was a prospective, multicenter, open-label, self-controlled study to evaluate the
 efficacy and safety of multi-parameter non-invasive glucose meters for blood glucose
 measurement，planned enrollment of 200 patients with type 1 or type 2 diabetes.
 
 Comparing glucose measurements from the Non-Invasive Glucose monitoring system to venous
 blood glucose or fingertip blood glucose to evaluate System accuracy capability.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06017349
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06017349 through Pure Global AI's free database. This phase not specified trial is sponsored by Lepu Medical Technology (Beijing) Co., Ltd. and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.